However, the effect of the PAR-2 antagonist, which exacerbated the decrease in body temperature in the anaphylaxis model, was abolished in mMCP-6 KO mice, suggesting that mMCP-6 may be involved in the inhibitory effect of PAR-2 on anaphylactic symptoms. Here, F2RL1 is linked to anaphylaxis.